Business Context and Reporting Period
Company: The Goodyear Tire & Rubber Company
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025 (Third Quarter)
Context: Goodyear is executing the "Goodyear Forward" transformation plan to optimize its portfolio, reduce costs, and improve margins. The quarter was marked by significant divestitures (OTR tire business, Dunlop brand rights, and polymer chemicals business), a major goodwill impairment, and the establishment of a full valuation allowance on U.S. deferred tax assets.
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $4,645 | $4,824 | $13,363 | $13,931 |
| Goodyear Net Income (Loss) | $(2,195) | $(37) | $(1,826) | $(27) |
| Net Income (Loss) Per Share (Diluted) | $(7.62) | $(0.13) | $(6.35) | $(0.09) |
| Total Segment Operating Income | $287 | $346 | $641 | $920 |
| Operating Margin (Segment) | 6.2% | 7.2% | 4.8% | 6.6% |
| Cash and Cash Equivalents | $810 | $905 | $810 | $985 |
| Unused Credit Availability | $2,547 | $3,555 | $2,547 | $3,555 |
| Long-Term Debt (excluding current) | $7,264 | $6,392 | $7,264 | $6,392 |
Material Changes vs. Prior Period
- Net Loss Expansion: The Q3 2025 net loss of $2.2 billion was driven primarily by a $1.46 billion non-cash income tax expense (establishment of a full valuation allowance on U.S. deferred tax assets), a $674 million goodwill impairment charge, and $68 million in pension settlement charges.
- Revenue Decline: Net sales decreased 3.7% in Q3 and 4.1% for the nine months ended Sept 30, 2025, due to lower global tire volumes, the impact of divestitures (OTR and Dunlop), and unfavorable foreign exchange rates, partially offset by price/mix improvements.
- Divestitures:
- OTR Tire Business: Sold to Yokohama for $905 million (Q1 2025), generating a $255 million pre-tax gain.
- Dunlop Brand: Sold to Sumitomo Rubber Industries for $526 million plus transition fees (Q2 2025), generating a $385 million pre-tax gain.
- Chemical Business: Sold for $650 million (Oct 31, 2025), with an estimated $135 million pre-tax gain to be recognized in Q4 2025.
- Goodwill Impairment: A full $674 million impairment was recorded for the North America reporting unit due to industry disruption, reduced outlook, and sustained stock price decline.
- Rationalization Costs: Net rationalization charges were $21 million in Q3 and $161 million for the nine months, related to facility closures (Kariega, Danville, Fulda, Fürstenwalde) and workforce reductions.
Guidance, Outlook, and Risks
- Q4 2025 Outlook:
- Global tire unit volume expected to decline ~4% vs. Q4 2024 due to high channel inventories.
- Raw material costs expected to decrease ~$5 million vs. Q4 2024.
- Price and product mix improvements expected to benefit results by ~$135 million.
- Non-raw material inflation, tariffs, and other costs expected to be ~$190 million higher vs. Q4 2024.
- Annualized tariff costs estimated at ~$300 million.
- Full Year 2025 Expectations:
- Goodyear Forward plan expected to deliver ~$750 million in segment operating income benefits.
- Capital expenditures expected to be ~$875 million.
- Working capital expected to be a use of cash of ~$150 million.
- Rationalization payments expected to be ~$450 million.
- Risks and Contingencies:
- Tax Matters: Full valuation allowance on U.S. deferred tax assets ($1.4 billion) due to cumulative losses and industry disruption. IRS Notice of Proposed Adjustment (NOPA) regarding a $1.5 billion intercompany IP sale; Goodyear plans to challenge this.
- Legal: Asbestos litigation with ~32,400 pending claims; EPA Notice of Violation regarding Clean Air Act violations at a former Texas facility.
- Liquidity: While liquidity is deemed adequate, access to capital markets is uncertain, and a significant portion of assets are already pledged as collateral.
Investor Verification Checklist
- Valuation Allowance: Verify the sustainability of the $1.4 billion U.S. deferred tax asset valuation allowance and the potential for reversal in future periods if earnings improve.
- Divestiture Gains: Confirm the final accounting for the Chemical Business sale ($135M estimated gain) and the timing of cash proceeds recognition.
- Goodwill Impairment: Assess the long-term impact of the $674 million North America goodwill write-off on future earnings and segment valuation.
- Tariff Exposure: Monitor the realization of the projected $300 million annualized tariff cost and its impact on margins.
- Debt Covenants: Review compliance with financial covenants, specifically the EBITDA to Interest Expense ratio and the borrowing base limitations on the revolving credit facility.
- Asbestos Reserves: Evaluate the adequacy of the $116 million asbestos liability reserve against the 32,400 pending claims and potential insurance recoveries.